Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 254

    1.

    The role of carbapenems in initial therapy for serious Gram-negative infections.

    Rahal JJ.

    Crit Care. 2008;12 Suppl 4:S5. Epub 2008 May 21. Review.PMID: 18495062 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Appropriate and timely empirical antimicrobial treatment of icu infections--a role for carbapenems.

    Colardyn F.

    Acta Clin Belg. 2005 Mar-Apr;60(2):51-62. Review.PMID: 16082989 [PubMed - indexed for MEDLINE]Related articles

    3.

    Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum.

    McGowan JE Jr.

    Am J Med. 2006 Jun;119(6 Suppl 1):S29-36; discussion S62-70. Review.PMID: 16735148 [PubMed - indexed for MEDLINE]Related articles

    4.

    The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.

    Merz LR, Warren DK, Kollef MH, Fridkin SK, Fraser VJ.

    Chest. 2006 Dec;130(6):1672-8.PMID: 17166981 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Multidrug-resistant Gram-negative bacterial infections: the emerging threat and potential novel treatment options.

    Vergidis PI, Falagas ME.

    Curr Opin Investig Drugs. 2008 Feb;9(2):176-83. Review.PMID: 18246520 [PubMed - indexed for MEDLINE]Related articles

    6.

    Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy.

    Paterson DL.

    Clin Infect Dis. 2008 Sep 15;47 Suppl 1:S14-20. Review.PMID: 18713045 [PubMed - indexed for MEDLINE]Related articles

    7.

    Antimicrobial resistance among and therapeutic options against gram-negative pathogens.

    Rahal JJ.

    Clin Infect Dis. 2009 Aug 15;49 Suppl 1:S4-S10.PMID: 19619021 [PubMed - indexed for MEDLINE]Related articles

    8.

    Gram-negative antibiotic resistance: there is a price to pay.

    Slama TG.

    Crit Care. 2008;12 Suppl 4:S4. Epub 2008 May 21. Review.PMID: 18495061 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The current state of multidrug-resistant gram-negative bacilli in North America.

    Nicasio AM, Kuti JL, Nicolau DP.

    Pharmacotherapy. 2008 Feb;28(2):235-49. Review.PMID: 18225969 [PubMed - indexed for MEDLINE]Related articles

    10.

    Optimizing the use of carbapenems in the face of increasing Gram-negative resistance.

    Ramphal R.

    Crit Care. 2008;12 Suppl 4:S1. Epub 2008 May 21. No abstract available. PMID: 18495058 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Doripenem.

    Anderson DL.

    Drugs Today (Barc). 2006 Jun;42(6):399-404. Review.PMID: 16845443 [PubMed - indexed for MEDLINE]Related articles

    12.

    Impact of multiresistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay.

    Sostarich AM, Zolldann D, Haefner H, Luetticken R, Schulze-Roebecke R, Lemmen SW.

    Infection. 2008 Feb;36(1):31-5. Epub 2008 Jan 29.PMID: 18231721 [PubMed - indexed for MEDLINE]Related articles

    13.

    The use of carbapenems in the treatment of serious infections.

    Baughman RP.

    J Intensive Care Med. 2009 Jul-Aug;24(4):230-41. Epub 2009 Jul 17. Review.PMID: 19617229 [PubMed - indexed for MEDLINE]Related articles

    14.

    Tigecycline: the answer to beta-lactam and fluoroquinolone resistance?

    Fraise AP.

    J Infect. 2006 Nov;53(5):293-300. Epub 2006 Jul 28. Review.PMID: 16876253 [PubMed - indexed for MEDLINE]Related articles

    15.

    Empiric treatment of nosocomial intra-abdominal infections: a focus on the carbapenems.

    Tellado JM, Wilson SE.

    Surg Infect (Larchmt). 2005 Fall;6(3):329-43. Review.PMID: 16201943 [PubMed - indexed for MEDLINE]Related articles

    16.

    Applying antimicrobial pharmacodynamics to resistant gram-negative pathogens.

    Scheetz MH, Hurt KM, Noskin GA, Oliphant CM.

    Am J Health Syst Pharm. 2006 Jul 15;63(14):1346-60. Review.PMID: 16809756 [PubMed - indexed for MEDLINE]Related articles

    17.

    Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenems.

    Kollef MH.

    Respir Care. 2004 Dec;49(12):1530-41. Review.PMID: 15571647 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Parenteral carbapenems.

    Shah PM.

    Clin Microbiol Infect. 2008 Jan;14 Suppl 1:175-80. Review. Erratum in: Clin Microbiol Infect. 2008 May;14 Suppl 5:21-4. PMID: 18154543 [PubMed - indexed for MEDLINE]Related articles

    19.

    Beta-lactam resistance in the gram negatives: increasing complexity of conditional, composite and multiply resistant phenotypes.

    Iredell J, Thomas L, Espedido B.

    Pathology. 2006 Dec;38(6):498-506. Review.PMID: 17393976 [PubMed - indexed for MEDLINE]Related articles

    20.

    Gram-negative bacterial resistance: evolving patterns and treatment paradigms.

    Kollef MH.

    Clin Infect Dis. 2005 Feb 15;40 Suppl 2:S85-8.PMID: 15712101 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data